Get started
Author

Ana Carolina Costi

Observed names: A.C Costi, A.C. Costi, ANA CAROLINA COSTI, Ana C Costi, Ana C. Costi, Ana Costi
ORCID: 0000-0002-1400-9810
Observed ORCID: 0000-0002-1400-9810
OpenAlex ID: A5064226630
Myositis-specific antibodies and clinical characteristics in patients with autoimmune inflammatory myopathies: reported by the Argentine Registry of Inflammatory Myopathies of the Argentine Society of Rheumatology
2021 · Graciela N. Gómez, Nicolás Pérez, et al. · Clinical Rheumatology · 23
Evaluación de las necesidades educacionales de los pacientes con artritis reumatoide mediante el cuestionario SpENAT
2018 · Silvana Pérez, María Santa Cruz, et al. · Reumatología Clínica · 10
Risk Factors for Relapse and/or Prolonged Glucocorticoid Therapy in Polymyalgia Rheumatica: Multicenter Study in 185 Patients
2023 · Juan Pablo Vinicki, Oscar Gut, et al. · JCR Journal of Clinical Rheumatology · 8
Validation of the adjusted global antiphospholipid syndrome score in systemic lupus erythematosus patients in Argentina
2020 · Lucila Garcia, Maria S Velloso, et al. · Lupus · 7
Evaluation of the educational needs in Argentine patients with rheumatoid arthritis using the SpENAT questionnaire
2019 · Silvana Pérez, María Santa Cruz, et al. · Reumatología Clínica (English Edition) · 7
Severe infections in systemic necrotizing vasculitis
2024 · Claudia Pena, Ana Carolina Costi, et al. · Reumatología Clínica (English Edition) · 3
Infecciones graves en vasculitis necrosantes sistémicas
2024 · Claudia Pena, Ana Carolina Costi, et al. · Reumatología Clínica · 1
Ab0202 Dysphagia: Poor Prognosis in Idiopathic Inflammatory Myopathies
2019 · ANA CAROLINA COSTI, Claudia Pena, et al. · Annals of the Rheumatic Diseases · 1
Access, Effectiveness, Safety, and Survival of Secukinumab in Patients With Axial Spondyloarthritis and Axial Psoriatic Arthritis: A Real-World Study in Argentina
2025 · María Victoria Martire, Josefina Marin, et al. · The Journal of Rheumatology
Ab0899 Rituximab in Inflammatory Myopathies: a Single Center Experience
2023 · A.C. Costi, C. Pena, et al. · Annals of the Rheumatic Diseases
PDF
Ab1207 Risk Factors for Higher Relapse Rate And/or Prolonged Glucocorticoid Therapy in Polymyalgia Rheumatica: Multicentre Study in 185 Patients
2022 · A. Cusa, O. Gut, et al. · Annals of the Rheumatic Diseases
PDF
Pos0660 Survival and Safety of Biological and Targeted Synthetic Therapies. 10 Years of Real-life Data. Bioabasar 3.0 Registry
2022 · A. Brigante, C.A. Isnardi, et al. · Annals of the Rheumatic Diseases
PDF
Ab0565 Hospitalization in a Cohort of Patients With Idiopathic Inflammatory Myopathy: What Is Happening in Argentina?
2020 · F. Arizpe, M. Cosentino, et al. · Annals of the Rheumatic Diseases
PDF
Ab0519 Pulmonary Involvement in Anca Associated Vasculitis (aav) According to Antigenic Specificity: a Retrospective Argentine Cohort
2020 · C. Pena, F. Savy, et al. · Annals of the Rheumatic Diseases
Association between Rheumatoid Arthritis and other autoimmune diseases
2020 · Eliana Rebeca Serrano, Silvana Karina Pérez, et al. · Revista Argentina de Reumatología
PDF
AB0725 Severe dysphagia “poor prognostic marker” in idiopathic inflammatory myopathies
2018 · A.C. Costi, L. Garcìa, et al. · Annals of the Rheumatic Diseases
PDF
AB1412-HPR Is diffuse alveolar haemorrhage in anca- associated vasculitis predictive of poor prognosis?
2018 · L. Garcia, C. Pena, et al. · Annals of the Rheumatic Diseases
PDF
Works count: 17
Citation count: 60
H-index: 5
I10-index: 2
Year
Topic
Type